Selected research
Market Structure
Global Rilpivirine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Rilpivirine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Rilpivirine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Rilpivirine include Aspen, Gilead Sciences, Janssen Cilag International, Pharmacare Limited, Strides Pharma Science Limited and ViiV Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Rilpivirine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Rilpivirine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Rilpivirine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rilpivirine market size, projected growth trends, production technologies, key applications, and end-use industries.
Rilpivirine Segment by Company
Aspen
Gilead Sciences
Janssen Cilag International
Pharmacare Limited
Strides Pharma Science Limited
ViiV Healthcare
Rilpivirine Segment by Type
Self-production API
Outsourcing of API
Rilpivirine Segment by Application
Clinic
Hospital
Drug Center
Others
Rilpivirine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rilpivirine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rilpivirine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rilpivirine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Rilpivirine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rilpivirine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rilpivirine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Rilpivirine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Self-production API
- Outsourcing of API
Applications
- Clinic
- Hospital
- Drug Center
- Others
Companies covered
- Aspen
- Gilead Sciences
- Janssen Cilag International
- Pharmacare Limited
- Strides Pharma Science Limited
- ViiV Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Rilpivirine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Rilpivirine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Rilpivirine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Rilpivirine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Rilpivirine Market Dynamics
- 2.1 Rilpivirine Industry Trends
- 2.2 Rilpivirine Industry Drivers
- 2.3 Rilpivirine Industry Opportunities and Challenges
- 2.4 Rilpivirine Industry Restraints
3 Rilpivirine Market by Manufacturers
- 3.1 Global Rilpivirine Revenue by Manufacturers (2021-2026)
- 3.2 Global Rilpivirine Sales by Manufacturers (2021-2026)
- 3.3 Global Rilpivirine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Rilpivirine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Rilpivirine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Rilpivirine Manufacturers, Product Type & Application
- 3.7 Global Rilpivirine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Rilpivirine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Rilpivirine Players Market Share by Revenue in 2025
- 3.8.3 2025 Rilpivirine Tier 1, Tier 2, and Tier 3
4 Rilpivirine Market by Type
- 4.1 Rilpivirine Type Introduction
- 4.1.1 Self-production API
- 4.1.2 Outsourcing of API
- 4.2 Global Rilpivirine Sales by Type
- 4.2.1 Global Rilpivirine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Rilpivirine Sales by Type (2021-2032)
- 4.2.3 Global Rilpivirine Sales Market Share by Type (2021-2032)
- 4.3 Global Rilpivirine Revenue by Type
- 4.3.1 Global Rilpivirine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Rilpivirine Revenue by Type (2021-2032)
- 4.3.3 Global Rilpivirine Revenue Market Share by Type (2021-2032)
5 Rilpivirine Market by Application
- 5.1 Rilpivirine Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Drug Center
- 5.1.4 Others
- 5.2 Global Rilpivirine Sales by Application
- 5.2.1 Global Rilpivirine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Rilpivirine Sales by Application (2021-2032)
- 5.2.3 Global Rilpivirine Sales Market Share by Application (2021-2032)
- 5.3 Global Rilpivirine Revenue by Application
- 5.3.1 Global Rilpivirine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Rilpivirine Revenue by Application (2021-2032)
- 5.3.3 Global Rilpivirine Revenue Market Share by Application (2021-2032)
6 Global Rilpivirine Sales by Region
- 6.1 Global Rilpivirine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Rilpivirine Sales by Region (2021-2032)
- 6.2.1 Global Rilpivirine Sales by Region (2021-2026)
- 6.2.2 Global Rilpivirine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Rilpivirine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Rilpivirine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Rilpivirine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Rilpivirine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Rilpivirine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Rilpivirine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Rilpivirine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Rilpivirine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Rilpivirine Revenue by Region
- 7.1 Global Rilpivirine Revenue by Region
- 7.1.1 Global Rilpivirine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Rilpivirine Revenue by Region (2021-2026)
- 7.1.3 Global Rilpivirine Revenue by Region (2027-2032)
- 7.1.4 Global Rilpivirine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Rilpivirine Revenue (2021-2032)
- 7.2.2 North America Rilpivirine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Rilpivirine Revenue (2021-2032)
- 7.3.2 Europe Rilpivirine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Rilpivirine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Rilpivirine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Rilpivirine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Rilpivirine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Aspen
- 8.1.1 Aspen Company Information
- 8.1.2 Aspen Business Overview
- 8.1.3 Aspen Rilpivirine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Aspen Rilpivirine Product Portfolio
- 8.1.5 Aspen Recent Developments
- 8.2 Gilead Sciences
- 8.2.1 Gilead Sciences Company Information
- 8.2.2 Gilead Sciences Business Overview
- 8.2.3 Gilead Sciences Rilpivirine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Gilead Sciences Rilpivirine Product Portfolio
- 8.2.5 Gilead Sciences Recent Developments
- 8.3 Janssen Cilag International
- 8.3.1 Janssen Cilag International Company Information
- 8.3.2 Janssen Cilag International Business Overview
- 8.3.3 Janssen Cilag International Rilpivirine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Janssen Cilag International Rilpivirine Product Portfolio
- 8.3.5 Janssen Cilag International Recent Developments
- 8.4 Pharmacare Limited
- 8.4.1 Pharmacare Limited Company Information
- 8.4.2 Pharmacare Limited Business Overview
- 8.4.3 Pharmacare Limited Rilpivirine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pharmacare Limited Rilpivirine Product Portfolio
- 8.4.5 Pharmacare Limited Recent Developments
- 8.5 Strides Pharma Science Limited
- 8.5.1 Strides Pharma Science Limited Company Information
- 8.5.2 Strides Pharma Science Limited Business Overview
- 8.5.3 Strides Pharma Science Limited Rilpivirine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Strides Pharma Science Limited Rilpivirine Product Portfolio
- 8.5.5 Strides Pharma Science Limited Recent Developments
- 8.6 ViiV Healthcare
- 8.6.1 ViiV Healthcare Company Information
- 8.6.2 ViiV Healthcare Business Overview
- 8.6.3 ViiV Healthcare Rilpivirine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 ViiV Healthcare Rilpivirine Product Portfolio
- 8.6.5 ViiV Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Rilpivirine Value Chain Analysis
- 9.1.1 Rilpivirine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Rilpivirine Production Mode & Process
- 9.2 Rilpivirine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Rilpivirine Distributors
- 9.2.3 Rilpivirine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst